Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Adenosine A2B Receptor: From Cell Biology to Human Diseases.

Sun Y, Huang P.

Front Chem. 2016 Aug 24;4:37. doi: 10.3389/fchem.2016.00037. eCollection 2016. Review.

2.

Attenuation of Pulmonary Ischemia-Reperfusion Injury by Adenosine A2B Receptor Antagonism.

Huerter ME, Sharma AK, Zhao Y, Charles EJ, Kron IL, Laubach VE.

Ann Thorac Surg. 2016 Aug;102(2):385-393. doi: 10.1016/j.athoracsur.2016.02.060. Epub 2016 Apr 22.

PMID:
27109193
3.

Adenosine influences myeloid cells to inhibit aeroallergen sensitization.

Pei H, Linden J.

Am J Physiol Lung Cell Mol Physiol. 2016 May 15;310(10):L985-92. doi: 10.1152/ajplung.00330.2015. Epub 2016 Mar 25.

4.

A2B adenosine receptor activation switches differentiation of bone marrow cells to a CD11c(+)Gr-1(+) dendritic cell subset that promotes the Th17 response.

Liang D, Zuo A, Shao H, Chen M, Kaplan HJ, Sun D.

Immun Inflamm Dis. 2015 Jul 30;3(4):360-73. doi: 10.1002/iid3.74. eCollection 2015 Dec.

5.

Purinergic signalling and immune cells.

Burnstock G, Boeynaems JM.

Purinergic Signal. 2014 Dec;10(4):529-64. doi: 10.1007/s11302-014-9427-2. Epub 2014 Oct 29. Review.

6.

Discovery of LAS101057: A Potent, Selective, and Orally Efficacious A2B Adenosine Receptor Antagonist.

Eastwood P, Esteve C, González J, Fonquerna S, Aiguadé J, Carranco I, Doménech T, Aparici M, Miralpeix M, Albertí J, Córdoba M, Fernández R, Pont M, Godessart N, Prats N, Loza MI, Cadavid MI, Nueda A, Vidal B.

ACS Med Chem Lett. 2010 Dec 20;2(3):213-8. doi: 10.1021/ml100249e. eCollection 2011 Mar 10.

7.

Role of JunB in adenosine A2B receptor-mediated vascular endothelial growth factor production.

Ryzhov S, Biktasova A, Goldstein AE, Zhang Q, Biaggioni I, Dikov MM, Feoktistov I.

Mol Pharmacol. 2014 Jan;85(1):62-73. doi: 10.1124/mol.113.088567. Epub 2013 Oct 17.

8.

Biological functions of ecto-enzymes in regulating extracellular adenosine levels in neoplastic and inflammatory disease states.

Longhi MS, Robson SC, Bernstein SH, Serra S, Deaglio S.

J Mol Med (Berl). 2013 Feb;91(2):165-72. doi: 10.1007/s00109-012-0991-z. Epub 2013 Jan 6. Review.

9.

A novel mechanism of control of NFκB activation and inflammation involving A2B adenosine receptors.

Sun Y, Duan Y, Eisenstein AS, Hu W, Quintana A, Lam WK, Wang Y, Wu Z, Ravid K, Huang P.

J Cell Sci. 2012 Oct 1;125(Pt 19):4507-17. doi: 10.1242/jcs.105023. Epub 2012 Jul 5.

10.

ATP release and autocrine signaling through P2X4 receptors regulate γδ T cell activation.

Manohar M, Hirsh MI, Chen Y, Woehrle T, Karande AA, Junger WG.

J Leukoc Biol. 2012 Oct;92(4):787-94. doi: 10.1189/jlb.0312121. Epub 2012 Jun 29.

11.

Mast cell adenosine receptors function: a focus on the a3 adenosine receptor and inflammation.

Rudich N, Ravid K, Sagi-Eisenberg R.

Front Immunol. 2012 Jun 4;3:134. doi: 10.3389/fimmu.2012.00134. eCollection 2012.

12.

Role of A2B adenosine receptors in regulation of paracrine functions of stem cell antigen 1-positive cardiac stromal cells.

Ryzhov S, Goldstein AE, Novitskiy SV, Blackburn MR, Biaggioni I, Feoktistov I.

J Pharmacol Exp Ther. 2012 Jun;341(3):764-74. doi: 10.1124/jpet.111.190835. Epub 2012 Mar 19.

13.

Perspectives of purinergic signaling in stem cell differentiation and tissue regeneration.

Glaser T, Cappellari AR, Pillat MM, Iser IC, Wink MR, Battastini AM, Ulrich H.

Purinergic Signal. 2012 Sep;8(3):523-37. doi: 10.1007/s11302-011-9282-3. Epub 2011 Dec 6. Review.

14.

Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells.

Ryzhov S, Novitskiy SV, Goldstein AE, Biktasova A, Blackburn MR, Biaggioni I, Dikov MM, Feoktistov I.

J Immunol. 2011 Dec 1;187(11):6120-9. doi: 10.4049/jimmunol.1101225. Epub 2011 Oct 28.

15.

IL-4 amplifies the pro-inflammatory effect of adenosine in human mast cells by changing expression levels of adenosine receptors.

Hua X, Chason KD, Patel JY, Naselsky WC, Tilley SL.

PLoS One. 2011;6(9):e24947. doi: 10.1371/journal.pone.0024947. Epub 2011 Sep 26.

16.

Role of adenosine A(2B) receptors in inflammation.

Feoktistov I, Biaggioni I.

Adv Pharmacol. 2011;61:115-44. doi: 10.1016/B978-0-12-385526-8.00005-9. Review.

17.

Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death.

Burnstock G, Verkhratsky A.

Cell Death Dis. 2010;1:e9. doi: 10.1038/cddis.2009.11. Review.

18.

A2B adenosine receptor blockade enhances macrophage-mediated bacterial phagocytosis and improves polymicrobial sepsis survival in mice.

Belikoff BG, Hatfield S, Georgiev P, Ohta A, Lukashev D, Buras JA, Remick DG, Sitkovsky M.

J Immunol. 2011 Feb 15;186(4):2444-53. doi: 10.4049/jimmunol.1001567. Epub 2011 Jan 17.

19.

Tissue-derived proinflammatory effect of adenosine A2B receptor in lung ischemia-reperfusion injury.

Anvari F, Sharma AK, Fernandez LG, Hranjec T, Ravid K, Kron IL, Laubach VE.

J Thorac Cardiovasc Surg. 2010 Oct;140(4):871-7. doi: 10.1016/j.jtcvs.2010.06.051. Epub 2010 Jul 24.

20.

Alterations in adenosine metabolism and signaling in patients with chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis.

Zhou Y, Murthy JN, Zeng D, Belardinelli L, Blackburn MR.

PLoS One. 2010 Feb 16;5(2):e9224. doi: 10.1371/journal.pone.0009224.

Supplemental Content

Support Center